[1] VAN TILBORG E, DE THEIJE CGM, VAN HAL M, et al. Origin and dynamics of oligodendrocytes in the developing brain: Implications for perinatal white matter injury. Glia. 2018;66(2): 221-238.
[2] BACK SA. White matter injury in the preterm infant: pathology and mechanisms. Acta Neuropathol. 2017;134(3):331-349.
[3] BARATEIRO A, BRITES D, FERNANDES A. Oligodendrocyte Development and Myelination in Neurodevelopment: Molecular Mechanisms in Health and Disease. Curr Pharm Des. 2016;22(6):656-679.
[4] SALMASO N, JABLONSKA B, SCAFIDI J, et al. Neurobiology of premature brain injury. Nat Neurosci. 2014;17(3):341-346.
[5] ALIZADEH A, DYCK SM, KARIMI-ABDOLREZAEE S. Myelin damage and repair in pathologic CNS: challenges and prospects. Front Mol Neurosci. 2015;8:35.
[6] DIETZ KC, POLANCO JJ, POL SU, et al. Targeting human oligodendrocyte progenitors for myelin repair. Exp Neurol. 2016;283(Pt B):489-500.
[7] WANG S, BATES J, LI X, et al. Human iPSC-derived oligodendrocyte progenitor cells can myelinate and rescue a mouse model of congenital hypomyelination. Cell Stem Cell. 2013;12(2):252-264.
[8] YAMASHITA T, MIYAMOTO Y, BANDO Y, et al. Differentiation of oligodendrocyte progenitor cells from dissociated monolayer and feeder-free cultured pluripotent stem cells. PLoS One. 2017;12(2): e0171947.
[9] MCLANE LE, BOURNE JN, EVANGELOU AV, et al. Loss of Tuberous Sclerosis Complex1 in Adult Oligodendrocyte Progenitor Cells Enhances Axon Remyelination and Increases Myelin Thickness after a Focal Demyelination. J Neurosci. 2017;37(31):7534-7546.
[10] WANG C, LUAN Z, YANG Y, et al. High purity of human oligodendrocyte progenitor cells obtained from neural stem cells: suitable for clinical application. J Neurosci Methods. 2015;240:61-66.
[11] BUNGE RP. Glial cells and the central myelin sheath. Physiol Rev. 1968; 48(1):197-251.
[12] FILLEY CM, FIELDS RD. White matter and cognition: making the connection. J Neurophysiol. 2016;116(5):2093-2104.
[13] LESCA G, VANIER MT, CREISSON E, et al. X-linked adrenoleukodystrophy in a female proband: clinical presentation, biological diagnosis and family consequences. Arch Pediatr. 2005;12(8):1237-1240.
[14] Van der Knaap MS, Bugiani M. Leukodystrophies: a proposed classification system based on pathological changes and pathogenetic mechanisms. Acta Neuropathol. 2017;134(3): 351-382.
[15] KEOUGH MB, YONG VW. Remyelination therapy for multiple sclerosis. Neurotherapeutics. 2013;10(1):44-54.
[16] NISHIYAMA A, KOMITOVA M, SUZUKI R, et al. Polydendrocytes (NG2 cells): multifunctional cells with lineage plasticity. Nat Rev Neurosci. 2009;10(1):9-22.
[17] PAYNE SC, BARTLETT CA, SAVIGNI DL, et al. Early proliferation does not prevent the loss of oligodendrocyte progenitor cells during the chronic phase of secondary degeneration in a CNS white matter tract. PLoS One. 2013;8(6):e65710.
[18] ESPINOSA-JEFFREY A, BLANCHI B, BIANCOTTI JC, et al. Efficient Generation of Viral and Integration-Free Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes. Curr Protoc Stem Cell Biol. 2016; 39(1):2D.18.1-2D.18.28.
[19] HU BY, DU ZW, ZHANG SC. Differentiation of human oligodendrocytes from pluripotent stem cells. Nat Protoc. 2009;4(11):1614-1622.
[20] SANTOS AK, VIEIRA MS, VASCONCELLOS R, et al. Decoding cell signalling and regulation of oligodendrocyte differentiation. Semin Cell Dev Biol. 2019;95:54-73.
[21] NEWVILLE J, JANTZIE LL, CUNNINGHAM LA.Embracing oligodendrocyte diversity in the context of perinatal injury. Neural Regen Res. 2017; 12(10):1575-1585.
[22] BARATEIRO A, FERNANDES A. Temporal oligodendrocyte lineage progression: in vitro models of proliferation, differentiation and myelination. Biochim Biophys Acta. 2014;1843(9):1917-1929.
[23] HUGHES EG, KANG SH, FUKAYA M, et al. Oligodendrocyte progenitors balance growth with self-repulsion to achieve homeostasis in the adult brain. Nat Neurosci. 2013;16(6): 668-676.
[24] BERGLES DE, RICHARDSON WD. Oligodendrocyte Development and Plasticity. Cold Spring Harb Perspect Biol. 2015;8(2):a020453.
[25] YEUNG MS, ZDUNEK S, BERGMANN O, et al. Dynamics of oligodendrocyte generation and myelination in the human brain. Cell. 2014;159(4):766-774.
[26] EL WALY B, MACCHI M, CAYRE M, et al. Oligodendrogenesis in the normal and pathological central nervous system. Front Neurosci. 2014; 8:145.
[27] NAVE KA, WERNER HB. Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol. 2014;30: 503-533.
[28] BULLER B, CHOPP M, UENO Y, et al. Regulation of serum response factor by miRNA-200 and miRNA-9 modulates oligodendrocyte progenitor cell differentiation. Glia. 2012; 60(12):1906-1914.
[29] MCMURRAN CE, KODALI S, YOUNG A, et al. Clinical implications of myelin regeneration in the central nervous system. Expert Rev Neurother. 2018;18(2):111-123.
[30] CZEPIEL M, BODDEKE E, COPRAY S. Human oligodendrocytes in remyelination research. Glia. 2015;63(4): 513-530.
[31] OSORIO MJ, ROWITCH DH, TESAR P, et al. Concise Review: Stem Cell-Based Treatment of Pelizaeus- Merzbacher Disease. Stem Cells. 2017; 35(2):311-315.
[32] DOUVARAS P, RUSIELEWICZ T, KIM KH, et al. Epigenetic Modulation of Human Induced Pluripotent Stem Cell Differentiation to Oligodendrocytes. Int J Mol Sci. 2016;17(4). pii: E614.
[33] THIRUVALLUVAN A, CZEPIEL M, KAP YA, et al. Survival and Functionality of Human Induced Pluripotent Stem Cell-Derived Oligodendrocytes in a Nonhuman Primate Model for Multiple Sclerosis. Stem Cells Transl Med. 2016;5(11): 1550-1561.
[34] PIAO J, MAJOR T, AUYEUNG G, et al. Human embryonic stem cell-derived oligodendrocyte progenitors remyelinate the brain and rescue behavioral deficits following radiation. Cell Stem Cell. 2015;16(2): 198-210.
[35] MARTEYN A, SARRAZIN N, YAN J, et al. Modulation of the Innate Immune Response by Human Neural Precursors Prevails over Oligodendrocyte Progenitor Remyelination to Rescue a Severe Model of Pelizaeus-Merzbacher Disease. Stem Cells. 2016;34(4):984-996.
[36] MAGNANI D, CHANDRAN S, WYLLIE DJA, et al. In Vitro Generation and Electrophysiological Characterization of OPCs and Oligodendrocytes from Human Pluripotent Stem Cells. Methods Mol Biol. 2019;1936: 65-77.
[37] PRASAD A, TEH DBL, BLASIAK A, et al. Static Magnetic Field Stimulation Enhances Oligodendrocyte Differentiation and Secretion of Neurotrophic Factors. Sci Rep. 2017;7(1): 6743.
[38] WANG C, ZHANG CJ, MARTIN BN, et al. IL-17 induced NOTCH1 activation in oligodendrocyte progenitor cells enhances proliferation and inflammatory gene expression. Nat Commun. 2017;8:15508.
[39] LIM CT, ZHOU EH, QUEK ST. Mechanical models for living cells--a review. J Biomech. 2006;39(2):195-216.
[40] JEN CJ, JHIANG SJ, CHEN HI. Invited review: effects of flow on vascular endothelial intracellular calcium signaling of rat aortas ex vivo. J Appl Physiol (1985). 2000;89(4):1657-1662, 1656.
[41] BACHRACH NM, VALHMU WB, STAZZONE E, et al. Changes in proteoglycan synthesis of chondrocytes in articular cartilage are associated with the time-dependent changes in their mechanical environment. J Biomech. 1995;28(12):1561-1569.
[42] LIU SQ. Influence of tensile strain on smooth muscle cell orientation in rat blood vessels. J Biomech Eng. 1998;120(3): 313-320.
[43] ZHANG C, ZHOU L, ZHANG F, et al. Mechanical remodeling of normally sized mammalian cells under a gravity vector. FASEB J. 2017;31(2): 802-813.
[44] 吕东媛,周吕文,龙勉.干细胞的生物力学研究[J].力学进展, 2017, 47(1): 534-585.
[45] WANG CY, DENEEN B, TZENG SF. BRCA1/BRCA2- containing complex subunit 3 controls oligodendrocyte differentiation by dynamically regulating lysine 63-linked ubiquitination. Glia. 2019;67(9):1775-1792.
[46] KAINDL J, MEISER I, MAJER J, et al. Zooming in on Cryopreservation of hiPSCs and Neural Derivatives: A Dual-Center Study Using Adherent Vitrification. Stem Cells Transl Med. 2019;8(3):247-259. |